# CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Sun Pharma UK Ltd
- Award value: £9,867,000
- Tender value: £9,867,000
- Award date: 14 January 2025
- Published: 21 January 2025
- Contract start: 1 February 2025
- Contract end: 31 May 2026
- Stage: awarded
- Procurement category: goods
- Notice ID: ffeee3ac-9be3-4ea0-8c54-091ab8be7d3f-819135
- OCID: ocds-b5fd17-e85a5f73-1208-4e45-a159-08011aef8a18

## Description

Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend \(at the discretion of the Authority\) up to maximum of 24 months\. Potential periods of call-offs under the framework agreement: CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection Lot 1 CESW: 01/02/2025 to 31/05/2026 \(16 months\) Lot 2 LSNE: 01/02/2025 to 31/05/2026 \(16 months\) Lot 3 NWLN: 01/02/2025 to 31/05/2026 \(16 months\) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

## Related contract awards

- [NASSTAR T1510 WTE Teams Telephony](/contracts/ocds-b5fd17-1bdf9a7a-14ea-4c0c-be0c-39fd8574a761): NHS England
- [NHP Information Management Project Controls Platform](/contracts/ocds-b5fd17-4fcc30c7-0eb2-417b-a7da-de99843314bd): NHS England
- [SolarWinds Licensing and Support - 2026-29](/contracts/ocds-b5fd17-6db83b63-5b91-42b9-bb0d-13c34a9c513c): NHS England
- [NHS Branded Medicines Tranche Framework for London and South of England](/contracts/ocds-b5fd17-093f7927-fa77-4248-beb7-0c8a9707d58c): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/ffeee3ac-9be3-4ea0-8c54-091ab8be7d3f-819135)